SHERPACEUTICALS Trademark

Trademark Overview

On Monday, February 20, 2023, a trademark application was filed for SHERPACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SHERPACEUTICALS trademark a serial number of 97802030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 23, 2025. This trademark is owned by Skin Sherpa North America, LLC. The SHERPACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for humans for diabetes
sherpaceuticals

General Information

Serial Number97802030
Word MarkSHERPACEUTICALS
Filing DateMonday, February 20, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for humans for diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSkin Sherpa North America, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78258
Party NameSkin Sherpa North America, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78258

Trademark Events

Event DateEvent Description
Friday, November 17, 2023ASSIGNED TO EXAMINER
Friday, November 17, 2023NON-FINAL ACTION WRITTEN
Friday, November 17, 2023NON-FINAL ACTION E-MAILED
Friday, November 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 6, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 23, 2023NEW APPLICATION ENTERED
Thursday, March 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 6, 2024PETITION TO REVIVE-GRANTED
Wednesday, March 6, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, March 6, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, March 6, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 6, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, August 20, 2024ASSIGNED TO LIE
Wednesday, September 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 23, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, June 23, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

sherpaceuticals diabetes humans preparations pharmaceutical